oa SA Pharmaceutical Journal - New drug focus

Volume 73, Issue 9
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Extracted from text ... SA Pharmaceutical Journal - October 2006 46 DRUG INFO Information supplied by Amayeza Info Services Tel : (011) 678 2332 Stresam(r) - A new nonbenzodiazepine for anxiety Approved indication Etifoxine (Stresam(r)) is indicated for the short-term treatment of the psychosomatic manifestations of anxiety. It treats both the psychological and the somatic (functional) consequences of anxiety. Mode of action Etifoxine is structurally unrelated to the benzodiazepines. Chemically, it is a benzoxazine that has a dual action on gamma amino butyric acid (GABA) and works both by interacting with the chloride channel of GABAA receptors and also by increasing GABAergic neurotransmission. Etifoxine ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error